Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10589175 | 0.80 | PRMT1 (0.52) | ALDH1A1MAPTTDP1TSHRPOLB | |
| SCHEMBL27637513 | 0.79 | ALDH1A1 (0.59) | ALDH1A1CTSDMAPTTDP1GAA | |
| SCHEMBL411359 | 0.79 | ALDH1A1 (0.59) | ALDH1A1CTSDMAPTTDP1GAA | |
| SCHEMBL28085190 | 0.79 | ALDH1A1 (0.50) | ALDH1A1CTSDMAPTTDP1GAA | |
| SCHEMBL20987678 | 0.79 | ALDH1A1 (0.63) | ALDH1A1CTSDMAPTTDP1GAA | |
| Benzoic Acid SCHEMBL6556466 | 0.78 | TSHR (0.59) | ALDH1A1CTSDMAPTTDP1GAA | |
| SCHEMBL3279313 | 0.78 | TSHR (0.54) | ALDH1A1CTSDMAPTTDP1GAA | |
| Water SCHEMBL4951772 | 0.78 | ALDH1A1 (0.58) | ALDH1A1CTSDMAPTTDP1GAA | |
| SCHEMBL28783981 | 0.78 | ALDH1A1 (0.58) | ALDH1A1CTSDMAPTTDP1GAA | |
| SCHEMBL1615014 | 0.78 | CES2 (0.69) | ALDH1A1CTSDMAPTTDP1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 602 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| EP-3172213-B1 | MACROCYCLIC KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2021-09-22 | — | — | EP | claimed |
| EP-3171874-B1 | IMIDAZOLYL KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2020-11-18 | — | — | EP | claimed |
| EP-2037762-A4 | METHOD TO PREPARE PURE CURCUMIN | KIM DARRICK S H L (US) | 2009-07-08 | — | — | EP | claimed |
| EP-2037762-A1 | METHOD TO PREPARE PURE CURCUMIN | Kim, Darrick S.H.L. (US) | 2009-03-25 | — | — | EP | claimed |
| WO-2007143635-A1 | METHOD TO PREPARE PURE CURCUMIN | KIM DARRICK S (US) | 2007-12-13 | — | — | WO | claimed |
| EP-4396354-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | Wave Life Sciences Ltd. (SG) | 2024-07-10 | — | — | EP | disclosed |
| CN-111936136-B | Novel imidazopyrimidine compounds and uses thereof | 儿童医学中心公司 | 2024-07-05 | — | — | CN | disclosed |
| WO-2024130218-A1 | STAPLED PEPTIDES AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024130217-A1 | STAPLED PEPTIDES AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| CN-114736219-B | Antitumor compounds | 法马马有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-114751920-B | Antitumor compounds | 法马马有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-118139977-A | Double-stranded oligonucleotide compositions and methods relating thereto | 波涛生命科学有限公司 | 2024-06-04 | — | — | CN | disclosed |
| WO-2000008044-A1 | 2'-O-AMINOETHYLOXYETHYL-MODIFIED OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 2000-02-17 | — | — | WO | disclosed |
| WO-1999066063-A2 | NUCLEOSIDIC AND NON-NUCLEOSIDIC FOLATE CONJUGATES | ISIS PHARMACEUTICALS, INC. (US) | 1999-12-23 | — | — | WO | disclosed |
| WO-1999014185-A1 | COMPOUNDS CONTAINING SIX-MEMBERED RINGS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS | GILEAD SCIENCES, INC. (US) | 1999-03-25 | — | — | WO | disclosed |
| WO-1999004789-A1 | SUBSTITUTED AURONE DERIVATIVES | PHYTERA, INC. (US) | 1999-02-04 | — | — | WO | disclosed |
| WO-1997026873-A1 | ANTIMICROBIAL AURONE DERIVATIVES | PHYTERA, INC. (US) | 1997-07-31 | — | — | WO | disclosed |
| EP-0759917-A1 | NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES | GILEAD SCIENCES, INC. (US) | 1997-03-05 | — | — | EP | disclosed |
| EP-0541042-A1 | 2,4- and 2,5-pyridine-dicarboxylic acid derivatives, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-05-12 | — | — | EP | disclosed |